These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4419015)

  • 1. [Free and combined protease inhibitors in bronchial mucus in patients with extended chronic obstructive airway diseases (author's transl)].
    Hochstrasser K; Rasche B; Reichert R; Hochgesand K
    Pneumonologie; 1974; 150(2-4):253-9. PubMed ID: 4419015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inter-alpha-trypsin inhibitor in serum and bronchial mucus inhibitor in sputum in chronic airway obstruction (author's transl)].
    Rasche B; Hochstrasser K; Ulmer WT
    Respiration; 1978; 36(1):39-47. PubMed ID: 307266
    [No Abstract]   [Full Text] [Related]  

  • 3. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy].
    Rasche B; Hochstrasser K
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():725-7. PubMed ID: 6557570
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction.
    Rasche B
    Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of masked specific proteinase inhibitor from bronchial secretions in purulent sputum as complex with leucocytic proteinases.
    Hochstrasser K; Schorn K; Rasche B; Lemparth K; Raffelt Ch
    Pneumonologie; 1975 Sep; 152(1-3):15-24. PubMed ID: 1187387
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
    Rasche B; Hochstrasser K; Marcic I; Ulmer WT
    Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentration of low-molecular protease inhibitor in the bronchial secretion in 1 -antitrypsin deficiency].
    Reichert R; Hochstrasser K; Fruhmann G; Fritz H; Werle E
    Pneumonologie; 1972; 147(1):41-5. PubMed ID: 5083260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Demonstration of a low-molecular protease inhibitor in human bronchial secretion].
    Reichert R; Hochstrasser K; Werle E
    Z Laryngol Rhinol Otol; 1972 Mar; 51(3):190-3. PubMed ID: 5027523
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protease inhibitors from lung, secretions and blood in horses and cattle: a comparative study on endogenous, predisposing factors of chronic obstructive lung disease].
    von Fellenberg R; Minder H; Wegmann C; Frei F
    Schweiz Arch Tierheilkd; 1979 Jul; 121(7):355-65. PubMed ID: 482922
    [No Abstract]   [Full Text] [Related]  

  • 10. [About the question of simultaneously occuring proteolytic and antiproteolytic activity in sputum in case of obstructive airway diseases (author's transl)].
    Hochstrasser K; Hochgesand K; Rasche B
    Respiration; 1974; 31(4):343-9. PubMed ID: 4842829
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities for inactivation of protease activity in sputum by protease inhibitors in chronic obstructive airway diseases].
    Rasche B; Ulmer WT
    Res Exp Med (Berl); 1972; 158(3):229-45. PubMed ID: 4117560
    [No Abstract]   [Full Text] [Related]  

  • 12. Benzo(a)pyrene hydroxylase activity in human bronchial mucus.
    Kapoor A; Batra JK; Luthra UK; Jain RC; Venkitasubramanian TA; Raj HG
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):33-7. PubMed ID: 3087751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The "IgA secretory component complex" in bronchial mucus in patients with chronic obstructive lung disease under different therapy (author's transl)].
    Rasche B; Curschmann P
    Respiration; 1979; 37(2):97-108. PubMed ID: 87005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification and characterization of proteins from human bronchial secretion (author's transl)].
    Laine A; Hayem A
    Clin Chim Acta; 1976 Mar; 67(2):159-67. PubMed ID: 1248152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of lysozyme for the viscosity of sputum from patients with chronic obstructive lung disease.
    Jenssen AO; Smidsrød O; Harbitz O
    Scand J Clin Lab Invest; 1980; 40(8):727-31. PubMed ID: 7280551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways.
    Kuhn C
    J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiproteases of bronchial mucus].
    Lebas J; Laine A; Hayem A
    Lille Med; 1976 Feb; 21(2):136-9. PubMed ID: 950872
    [No Abstract]   [Full Text] [Related]  

  • 18. [The protease-inhibitor capacity of human bronchial mucus. Content in low molecular inhibitor and 1 -antitrypsin under physiological and physiopathological conditions].
    Reichert R; Hochstrasser K; Conradi G
    Pneumonologie; 1972; 147(1):13-20. PubMed ID: 5083256
    [No Abstract]   [Full Text] [Related]  

  • 19. [Respiratory function and the rheological status of bronchial secretions collected by spontaneous expectoration and after physiotherapy (author's transl)].
    Pham QT; Peslin R; Puchelle E; Salmon D; Caraux G; Benis AM
    Bull Physiopathol Respir (Nancy); 1973; 9(2):293-314. PubMed ID: 4778953
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitors of proteases in bronchial secretion of patients deficient in alpha-l-antitrypsin].
    Laine A; Lebas J; Hayem A
    Lille Med; 1976 Feb; 21(2):140-3. PubMed ID: 1084948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.